Exogenous administration of the IDO1 pathway catabolites kynurenine and quinolinic acid led to activation of β-catenin and proliferation of human colon cancer cells, resulting in increased tumor growth in mice [98]. The gene discussed is IDO1; the disease is neoplasm.